CD8+T Cell-Mediated Immunity duringTrypanosoma cruziInfection: A Path for Vaccine Development?
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CD8+T Cell-Mediated Immunity duringTrypanosoma cruziInfection: A Path for Vaccine Development?
Authors
Keywords
-
Journal
MEDIATORS OF INFLAMMATION
Volume 2014, Issue -, Pages 1-12
Publisher
Hindawi Limited
Online
2014-07-02
DOI
10.1155/2014/243786
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bioluminescence imaging of chronicTrypanosoma cruziinfections reveals tissue-specific parasite dynamics and heart disease in the absence of locally persistent infection
- (2014) Michael D. Lewis et al. CELLULAR MICROBIOLOGY
- Adenovirus Vector-Induced CD8+ T Effector Memory Cell Differentiation and Recirculation, But Not Proliferation, Are Important for Protective Immunity Against Experimental Trypanosoma cruzi Infection
- (2014) José Ronnie Vasconcelos et al. HUMAN GENE THERAPY
- Serum-Mediated Activation of Macrophages Reflects TcVac2 Vaccine Efficacy against Chagas Disease
- (2014) Shivali Gupta et al. INFECTION AND IMMUNITY
- Infection with Trypanosoma cruzi Restricts the Repertoire of Parasite-Specific CD8+ T Cells Leading to Immunodominance
- (2014) F. Tzelepis et al. JOURNAL OF IMMUNOLOGY
- Effector-like CD8+ T Cells in the Memory Population Mediate Potent Protective Immunity
- (2013) Janelle A. Olson et al. IMMUNITY
- Recombinant Yellow Fever Viruses Elicit CD8+ T Cell Responses and Protective Immunity against Trypanosoma cruzi
- (2013) Raquel Tayar Nogueira et al. PLoS One
- TcVac3 Induced Control of Trypanosoma cruzi Infection and Chronic Myocarditis in Mice
- (2013) Shivali Gupta et al. PLoS One
- Vaccination Using Recombinants Influenza and Adenoviruses Encoding Amastigote Surface Protein-2 Are Highly Effective on Protection against Trypanosoma cruzi Infection
- (2013) Rafael Polidoro Alves Barbosa et al. PLoS One
- Accelerating the development of a therapeutic vaccine for human Chagas disease: rationale and prospects
- (2012) Eric Dumonteil et al. Expert Review of Vaccines
- High Interleukin 17 Expression Is Correlated With Better Cardiac Function in Human Chagas Disease
- (2012) Luisa M. D. Magalhães et al. JOURNAL OF INFECTIOUS DISEASES
- Inhibitory Receptors Are Expressed by Trypanosoma cruzi-Specific Effector T Cells and in Hearts of Subjects with Chronic Chagas Disease
- (2012) Rafael J. Argüello et al. PLoS One
- Re-circulation of lymphocytes mediated by sphingosine-1-phosphate receptor-1 contributes to resistance against experimental infection with the protozoan parasite Trypanosoma cruzi
- (2012) Mariana R. Dominguez et al. VACCINE
- CD8+ T-Cells Expressing Interferon Gamma or Perforin Play Antagonistic Roles in Heart Injury in Experimental Trypanosoma Cruzi-Elicited Cardiomyopathy
- (2012) Jaline Coutinho Silverio et al. PLoS Pathogens
- Pathogen-Induced Proapoptotic Phenotype and High CD95 (Fas) Expression Accompany a Suboptimal CD8+ T-Cell Response: Reversal by Adenoviral Vaccine
- (2012) José Ronnie Vasconcelos et al. PLoS Pathogens
- Genetically attenuated Trypanosoma cruzi parasites as a potential vaccination tool
- (2012) Cecilia Pérez Brandan et al. Bioengineered
- Relevance of long-lived CD8+ T effector memory cells for protective immunity elicited by heterologous prime-boost vaccination
- (2012) José R. Vasconcelos et al. Frontiers in Immunology
- Advances and challenges towards a vaccine against Chagas disease
- (2011) Israel Quijano-Hernandez et al. Human vaccines & immunotherapeutics
- Heterologous Plasmid DNA Prime-Recombinant Human Adenovirus 5 Boost Vaccination Generates a Stable Pool of Protective Long-Lived CD8+T Effector Memory Cells Specific for a Human Parasite, Trypanosoma cruzi
- (2011) Paula Ordonhez Rigato et al. INFECTION AND IMMUNITY
- Subdominant/Cryptic CD8 T Cell Epitopes Contribute to Resistance against Experimental Infection with a Human Protozoan Parasite
- (2011) Mariana R. Dominguez et al. PLoS One
- Regulatory T Cells Phenotype in Different Clinical Forms of Chagas' Disease
- (2011) Fernanda Fortes de Araújo et al. PLoS Neglected Tropical Diseases
- The endless race between Trypanosoma cruzi and host immunity: lessons for and beyond Chagas disease
- (2010) Caroline Junqueira et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- Chagas’ disease: an update on immune mechanisms and therapeutic strategies
- (2010) Silvia Beatriz Boscardin et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Redirection of the Immune Response to the Functional Catalytic Domain of the Cystein Proteinase Cruzipain Improves Protective Immunity againstTrypanosomacruziInfection
- (2010) Silvia I. Cazorla et al. JOURNAL OF INFECTIOUS DISEASES
- Country by country
- (2010) Anna Petherick NATURE
- Chagas disease: a new worldwide challenge
- (2010) José Rodrigues Coura et al. NATURE
- The Potential Economic Value of a Trypanosoma cruzi (Chagas Disease) Vaccine in Latin America
- (2010) Bruce Y. Lee et al. PLoS Neglected Tropical Diseases
- Vaccination approaches againstTrypanosoma cruziinfection
- (2009) Silvia Inés Cazorla et al. Expert Review of Vaccines
- Perforin and Gamma Interferon Expression Are Required for CD4+ and CD8+ T-Cell-Dependent Protective Immunity against a Human Parasite, Trypanosoma cruzi, Elicited by Heterologous Plasmid DNA Prime-Recombinant Adenovirus 5 Boost Vaccination
- (2009) B. C. G. de Alencar et al. INFECTION AND IMMUNITY
- Insufficient TLR Activation Contributes to the Slow Development of CD8+ T Cell Responses in Trypanosoma cruzi Infection
- (2009) A. M. Padilla et al. JOURNAL OF IMMUNOLOGY
- Cutting Edge: Nucleotide-Binding Oligomerization Domain 1-Dependent Responses Account for Murine Resistance against Trypanosoma cruzi Infection
- (2009) G. K. Silva et al. JOURNAL OF IMMUNOLOGY
- Efficient protective immunity against Trypanosoma cruzi infection after nasal vaccination with recombinant Sendai virus vector expressing amastigote surface protein-2
- (2009) Xuefeng Duan et al. VACCINE
- Novel Protective Antigens Expressed by Trypanosoma cruzi Amastigotes Provide Immunity to Mice Highly Susceptible to Chagas' Disease
- (2008) E. L. V. Silveira et al. Clinical and Vaccine Immunology
- Previously Unrecognized Vaccine Candidates Control Trypanosoma cruzi Infection and Immunopathology in Mice
- (2008) V. Bhatia et al. Clinical and Vaccine Immunology
- Current concepts in immunoregulation and pathology of human Chagas disease
- (2008) Walderez O Dutra et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Functional IL‐10 Gene Polymorphism Is Associated with Chagas Disease Cardiomyopathy
- (2008) Germano C. Costa et al. JOURNAL OF INFECTIOUS DISEASES
- Drug-induced cure drives conversion to a stable and protective CD8+ T central memory response in chronic Chagas disease
- (2008) Juan M Bustamante et al. NATURE MEDICINE
- Immunization with an engineered mutant trans-sialidase highly protects mice from experimental Trypanosoma cruzi infection: A vaccine candidate
- (2008) Germán H. Fontanella et al. VACCINE
- HLA Class I-T Cell Epitopes from trans-Sialidase Proteins Reveal Functionally Distinct Subsets of CD8+ T Cells in Chronic Chagas Disease
- (2008) María G. Alvarez et al. PLoS Neglected Tropical Diseases
- Trypanosoma cruzi infection from the view of CD8+ T cell immunity — An infection model for developing T cell vaccine
- (2007) Yasushi Miyahira PARASITOLOGY INTERNATIONAL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search